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Intestinal Enterocytes, Which Is Inhibited
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The mechanisms of diarrhea due to rotavirus infection in humans are not fully understood; no specific therapy
is available, but orally administered human serum immunoglobulins are effective in blocking stool output.
We aimed to investigate the effect of rotavirus on ion transport and the role of NSP4 in human-derived
enterocytes, and to test the efficacy of human serum immunoglobulin in a model of rotavirus infection. Soon
after infection, rotavirus induces active chloride secretion in enterocytes. This effect is evident before viral
replication leads to cell damage and correlates with NSP4 production. Inhibition of NSP4 prevents the early
secretory phase but not cell damage. Incubation with human serum immunoglobulin blocks both ion secretion
and cell damage. Rotavirus exerts an early NSP4-dependent ion secretion and subsequent tissue damage. The
combined enterotoxic and cytotoxic effects may be responsible for the increased severity of diarrhea due to
rotavirus infection, and both are counteracted by human serum immunoglobulin.
Acute gastroenteritis is a major cause of pediatric mor-
tality in developing countries and morbidity in more-
developed areas, and rotavirus is the most frequent eti-
ologic agent of gastroenteritis in children [1, 2]. Despite
the social and medical costs related to rotavirus gas-
troenteritis, no specific therapy is currently available.
Much effort has been put into the development of a
safe and effective vaccine, and currently, 2 different
vaccines are available [3, 4].
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Rotavirus gastroenteritis is more severe than that
caused by other common pathogens, but the reasons
for such increased severity are not fully understood [5].
Rotavirus infects mature enterocytes of small intestinal
villi, inducing a wide array of functional and structural
damages [6, 7]. Several lines of evidence suggest that
the destruction of enterocytes and malabsorption can-
not completely explain the pathogenesis of rotavirus
infection [8–11]. Moreover, early watery diarrhea oc-
curs prior to the detection of villous blunting and other
histological changes [11–14]. More recently, studies
from animal models led to the identification of novel
mechanisms responsible for intestinal secretion during
rotavirus infection. Rotavirus-infected cells release a
nonstructural protein encoded by the virus, called
NSP4, which is able to stimulate age-related and cal-
cium-dependent chloride secretion in mice [15, 16].
However, a complete demonstration of the sequence of
events taking place during rotavirus infection and lead-
ing to diarrhea is still lacking.
NSP4 is a glycoprotein that interacts with the viral
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capsid during rotavirus morphogenesis [17]. Viral sequencing
demonstrated high variability, which allowed the definition of
5 NSP4 genetic groups. However, genetic sequencing of NSP4
demonstrated that the variability is mainly located to the C-
terminal region of the peptide, between amino acids 110 and
140 in viruses from different species and strains, and this region
is important in the virulence of rotavirus [18, 19]. Despite of
the importance of NSP4 in the pathophysiology of rotavirus
diarrhea in animal models, attempts to detect NSP4 in human-
derived models have not been successful, and its role in human
disease remains to be elucidated [20].
Rotavirus infects Caco-2 cells, a human intestinal epithelial
cell line, and induces a cytotoxic effect with cell lysis and loss
of tissue integrity [21]. We previously demonstrated that human
serum immunoglobulins (Igs) counteract rotaviral infection in
Caco-2 cells, reducing cell damage through a direct anti-ro-
tavirus action [22]. The clinical use of enterally administered
Igs was proposed for severe and protracted rotaviral diarrhea
[23]. Subsequently, Igs efficacy was shown in children with
acute rotaviral diarrhea and in human immunodeficiency vi-
rus–infected children [24, 25]. Intriguingly, the effect of Igs was
remarkably evident in the very early phases of the disease [24].
In the present study, we investigated the direct effects of
rotavirus on transepithelial ion transport, and we were able to
set up a model of rotaviral diarrhea in vitro, to investigate the
role of NSP4. Finally we tested the efficacy of human serum
Igs in this model of rotavirus infection in vitro.
MATERIALS AND METHODS
Study design. The study was performed to clarify the se-
quence of events taking place at the level of the enterocyte that
are potentially responsible for diarrhea after rotavirus infection.
In the first part of the study, with use of the Ussing chamber
system, we addressed the effect of rotavirus on ion transport
and cell viability, namely the capacity of rotavirus to induce
chloride secretion and cell damage. Because Ca2+ is reported
to play a key role in rotavirus infection, we investigated the
involvement of Ca2+ in the electrical effects induced by rota-
virus. Subsequently, we investigated the mechanism of enter-
otoxicity. Because NSP4 was recognized to act as an enterotox-
in, we performed experiments to detect this peptide in rota-
virus-infected cells. Finally, neutralization experiments were
performed with human serum Igs and with specific anti-NSP4
antibodies.
Cell culture. Caco-2 cells were obtained from the Ameri-
can Type Culture Collection. Cells were grown in high glucose
Dulbecco’s modified eagle medium with 10% fetal calf serum,
1% nonessential amino acids, 50 mU/mL penicillin, and 50
mg/mL streptomycin, as described elsewhere [26]. Caco-2 cells
were grown for 15–18 days after confluence on nontransparent
polycarbonate Transwell filters (pore size, 0.4 mM) (Costar Ita-
lia). All studies were performed at passages 25–40.
Virus strain and infection protocol. The simian rotavirus
strain SA11 is well characterized and is able to replicate to high
titers in Caco-2 cells [27, 28]. Virus activation and cell infec-
tions were performed in differentiated Caco-2 cells as reported
elsewhere [22]. Briefly, the virus was activated with 20 mg/mL
trypsin for 30 min at 37C. Confluent monolayers of Caco-2
cells were washed twice and incubated overnight in fetal calf
serum–free medium before virus infection. Viral suspension
was added to the apical side of the cell monolayer. After 60
min of incubation at 37C, the cells were rinsed 3 times and
incubated in fetal calf serum–free medium for the established
times after infection. The time after infection was started after
removal of the excess viral particles. Viral load was determined
by plaque forming unit (PFU) assay with MA104 cells, as de-
scribed elsewhere [29].
Ion transport studies. Ion transport studies were per-
formed in an Ussing chamber model, as reported elsewhere
[26]. Briefly, cells were grown in monolayers on uncoated poly-
carbonate transwell filters. The filter area was 4.9 cm2. Each
filter was mounted in the chamber (WPI) as a flat sheet between
the mucosal and the serosal compartments. Each compartment
contained 5 mL of Ringer’s solution with the following com-
position: NaCl, 114 mmol/L; KCl, 5 mmol/L; Na2HPO4, 1.65
mmol/L; NaH2PO4, 0.3 mmol/L; CaCl2, 1.25 mmol/L; MgCl2,
1.1 mmol/L; NaHCO3, 25 mmol/L; and glucose, 10 mmol/L.
This solution was constantly gassed with 5% CO2, 95% O2 and
maintained at 37C through a thermostat-regulated circulating
pump.
Infection with rotavirus was performed with 5 PFUs of virus
per cell. The following electrical parameters were measured at
different time points after infection, as described elsewhere [30]:
transepithelial potential difference (PD), short-circuit current
(Isc), and tissue ionic conductance (G). Isc is expressed as mi-
croamperes per square centimeter (mA/cm2), G is expressed as
millisiemens per square centimeter (mS/cm2), and PD is ex-
pressed as millivolts (mV). Cell viability was evaluated at the
end of each experiment by the absence of significant loss in G
(!20% vs the baseline value) and by measuring the electrical
response to the serosal addition of theophylline (5 mmol/L).
Cells were considered to be viable and the experiment was
considered to be reliable when an Isc increase 15.0 mA/cm
2 was
observed after theophylline addition.
To investigate the role of Cl in the electrical response, SO4
2-
was substituted for Cl at an equimolar concentration. We also
used the Cl channel inhibitor 5-nitro-2–3-(3-phenylpropyl-
amino) benzoic acid (NPPB) as described elsewhere [31]. Cells
were incubated with NPPB (100 nmol/L) for 30 min before
being mounted in Ussing chambers.
In experiments investigating the role of Ca2+, a modified
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Ringer’s solution was used, with Mg2+ substituted for Ca2+ at
equimolar concentration, to bathe the mucosal side of the filter.
The modified Ringer’s solution had the following composition:
Na2HPO4, 1.65 mmol/L; NaH2PO4, 0.3 mmol/L; NaHCO3, 25
mmol/L; NaCl, 53 mmol/L; KCl, 5 mmol/L; Na2SO4, 30.5 mmol/
L; MgCl2, 2.35 mmol/L; glucose, 10 mmol/L; and mannitol, 30.5
mmol/L. In addition, we used the membrane-permeant Ca2+
chelator 1,2-bis(2-aminophenoxy)ethane N,N,N’,N’-tetraacetic
acid/acetoxymethyl ester (BAPTA/AM), as reported elsewhere
[31]. Cells were pretreated with 20 mmol/L BAPTA/AM on both
the mucosal and serosal sides, 30 min before being mounted in
Ussing chambers. To further investigate the role of Ca2+, we used
Bay K8644 as a Ca2+ inhibitor; we added 1 mmol/L of Bay K8644
20 min before mounting filters in Ussing chambers [32]. This
compound acts as a specific agonist of L-type Ca2+ channels,
causing depletion of intracellular Ca2+ stores [33].
Transepithelial resistance measurements. Transepithelial
resistance of cell monolayers grown on filters was measured
using a Millicel-ERS resistance monitoring apparatus (Milli-
pore). The net resistance was calculated by subtracting the
background from the actual value and multiplying the value
obtained by the area of the filter (4.9 cm2). The resistance was
expressed in ohms/cm2. Transepithelial resistance was measured
at 1 h intervals for the first 6 h after infection, then at 6 h
intervals for the first 24 h, and subsequently every 12 h for 3
days.
Chamber fluids and immunoprecipitation studies. Rota-
virus-infected and noninfected cells and chamber fluids were
separately collected at different time points after infection.
Chamber fluids were filtered through a 0.45-mm Millipore
membrane to get rid of cell debris. For experiments in Ussing
chambers, 500-mL aliquots of chamber fluids were collected
and normalized by protein content.
Cells were lysed by 3 cycles of freezing-thawing, then cen-
trifuged at 10,000 g for 3 min, and pellets were discarded. One
mL of the supernatant was diluted in 1 mL of 2 radioim-
munoprecipitation assay buffer (1% sodium deoxycholate, 2%
NP-40, 300 mmol/L NaCl, 100 mmol/L Tris pH 7.5, 0.2%
sodium dodecyl sulfate, 1 mg/mL aprotinin, 0.5 mg/mL leupep-
tin, 0.7 mg/mL pepstatin A, and 100 mg/mL phenylmethylsul-
fonyl fluoride). Immunoprecipitation was performed with 20
mL of rabbit polyclonal anti-NSP4fl antibody for 2 h at 4C.
Subsequently, 50 mL protein-A sepharose were added for 1 h
at 4C. Protein-A sepharose beads were centrifuged at 10,000
g for 30 s, the supernatant was removed, and the beads were
then washed 5 times with 1 mL of 1 radioimmunoprecipi-
tation assay buffer. The beads were again centrifuged, and 100
mL of 2 radioimmunoprecipitation assay buffer was added to
each sample, which were then incubated for 30 min at 37C.
The supernatants were separated by 14% sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis and were electrotrans-
ferred to nitrocellulose membranes (2). The membranes were
blotted with a different anti-NSP4 antibody (anti-NSP4114–135)
(1:1000) and with horseradish peroxidase-conjugated goat anti-
rabbit IgG. Antibody-specific proteins were visualized by chem-
iluminescence (Pierce), followed by exposure with Kodak X-
Omat film.
Neutralization experiments. After rotavirus infection, Ca-
co-2 cells were incubated with either human serum immu-
noglobulin preparation (1:5000) or both anti-NSP4 antibod-
ies (1:1000). Both human Igs and anti-NSP4 antibodies were
added 1 h after infection to both rotavirus infected and non-
infected cells. To investigate the effect of neutralization exper-
iments on ion secretion, we measured Isc modification at 2 h
after infection as an outcome parameter, because this was the
time point when the maximal enterotoxic rotavirus effect was
evident. To investigate the effect of neutralization experiments
on cell damage, we measured transepithelial resistance modi-
fication at 36 h after infection as an outcome parameter, be-
cause this was the time point when the maximal cytotoxic
rotavirus effect was evident.
Data collection and statistical analysis. All experiments
on ion transport involving the Ussing chamber system and
transepithelial resistance measurements were performed by1
operator, whereas data recording, collection, and analysis were
blindly performed by a different scientist. Similarly, the results
of all other experiments were all blindly analyzed by a scientist
other than the one who performed the experiments.
All experiments were performed in triplicate and repeated
at least 3 times. Numerical data are expressed as mean values
 standard error of the mean. Data were analyzed using the
2-tailed student’s t test.
Antibodies and reagents. All reagents were obtained from
Sigma if not otherwise stated. Human serum Igs were obtained
from a single commercially available batch for intravenous use,
with the following specific neutralizing titers: Rotavirus strain
Wa (serotype 1), 1:800; strain DS-1 (serotype 2), 1:1600; strain
Price (serotype 3), 1:3200; strain ST-3 (serotype 4), 1:1600.
Specific titers were determined as reported elsewhere [24]. Two
different anti-NSP4 antibodies were used. One was a rabbit
polyclonal antibody raised against a full length form of NSP4
(anti-NSP4fl) and was kindly supplied by L. Svensson (Uni-
versity of Linko¨ping, Sweden). The second one was a gift from
A. W. C. Einerhand (Erasmus MC-Sophia Children’s Hospital,
Rotterdam, the Netherlands) and was also a rabbit polyclonal
antibody raised against amino acids 114–135 of NSP4 from
SA11 strain (anti-NSP4114–135) [11].
RESULTS
Rotavirus infection induces an early chloride secretion, which
precedes tissue damage, in Caco-2 cells. Caco-2 cells infected
with rotavirus and mounted in Ussing chambers, showed an
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Figure 2. Sequential electrical modification induced by rotavirus in
Caco-2 cells. Rotavirus stimulates ion secretion in the early phases of
infection, as demonstrated by an increase in short circuit current (Isc)
(black squares). At the same time points after infection, tissue integrity
remains preserved, with transepithelial resistance (TER) (white diamonds)
remaining unaffected. At later time points, ion secretion is no longer
evident, whereas rotavirus begins to damage epithelial integrity, as dem-
onstrated by decrease in TER.
Figure 1. Short circuit current (Isc) modifications in rotavirus-infected
Caco-2 cells. Rotavirus is able to induce a time-dependent Isc increase
in enterocytes, which is consistent with anion secretion. Isc increase is
evident at 1 h after infection, peaks at 2 h after infection, and then
slowly decreases. Data are mean values  standard deviation of at
least 5 experiments. * .P ! .05
increase in Isc, compared with noninfected cells, which is con-
sistent with anion secretion (figure 1). The increase in Isc was
statistically significant at 1 h after infection, reaching a peak
after 2 h and then slowly decreasing. At 12 h after infection,
electrical evidence of active ion secretion was no longer detected
(figure 1). The secretory effect observed in rotavirus-infected
cells showed a common pattern with a progressive increase in
Isc, which is consistent with a persistent secretory tone.
To make sure that the electrical effect was dependent on
anion secretion rather than cation absorption, experiments
were performed using Cl-free Ringer’s solution at 2 h after
infection, this being the time point corresponding to the max-
imal effect on Isc. Without Cl
, the electrical effect was virtually
abolished (DIsc, vs with normal Ringer’s0.5 0.5 2.8 0.9
solution; ). To investigate the role of Cl in greater detail,P ! .05
we measured Isc modification in the presence of the Cl
 channel
inhibitor NPPB. NPPB completely inhibited the secretory effect
of rotavirus (DIsc, vs with normal Ringer’s0.3 0.3 2.8 0.9
solution; ). Thus, the effect of rotavirus on Isc was entirelyP ! .05
attributable to transepithelial Cl secretion.
Time course of the enterotoxic and cytotoxic effects in ro-
tavirus-infected cells. We analyzed together the time course
of the effects on ion secretion (reflected by Isc) and on tissue
integrity (reflected by transepithelial resistance) (figure 2). Tran-
sepithelial resistance did not change in the first few hours after
infection. Subsequently, after switching off secretion, starting
from 24 h after infection, the cytotoxic effect of the virus became
evident, as demonstrated by the decrease in transepithelial re-
sistance (figure 2). These electrical modifications account for a
sequence of distinct enterotoxic and cytotoxic mechanisms of
rotaviral diarrhea.
Role of calcium in rotavirus-mediated secretion. Rotavirus
infection in calcium-free Ringer’s solution failed to demon-
strated significant ion secretion (DIsc, vs0.6 0.4 2.8 0.9
with normal Ringer’s solution; ). Preincubation of cellsP ! .05
with both the calcium chelator BAPTA as well as the L-type
calcium channel inhibitor Bay K8644 was able to block rota-
virus-induced secretion (DIsc, and , respec-0.4 0.2 0.5 0.2
tively; , compared with standard Ringer’s solution). ThisP ! .05
suggests that the secretory effect of rotavirus is Ca2+ dependent.
In addition, specific inhibition of L-type Ca2+ channels com-
pletely blocked the electrical effects exerted by rotavirus, sug-
gesting that a major role in ion secretion is played by these
type of channels. This set of experiments was performed at 2
h after infection, because this time point corresponded to the
maximal effect on Isc.
Dependency on the viral load of rotavirus-mediated
secretion. We tested the effects of increasing loads of rotavirus
on ion secretion. Chloride secretion was detected after infection
with 1 PFU/cell (DIsc, ) and linearly increased with1.05 0.56
infection with 5 PFU/cell (DIsc, ; , compared2.8 0.95 P ! .01
with 1 PFU/cell) and 25 PFU/cell (DIsc, ; ,4.22 2.25 P ! .05
compared with 5 PFU/cell, and , compared with 1 PFU/P ! .01
cell). No further increase was observed at 50 PFU/cell, which
indicated a saturation pattern. In all other characterization ex-
periments, a single dose of 5 PFU/cell was used.
Chamber fluids from rotavirus-infected cells stimulate ion
secretion in noninfected cells. We investigated the presence
of enterotoxic moieties by adding aliquots of chamber fluids,
obtained from rotavirus-infected cells at different times after
infection, to the apical compartment of noninfected Caco-2
cells (figure 3). Their effect was compared with that of chamber
fluids from noninfected enterocytes and from cells challenged
with rotavirus but in which rotavirus was neither activated with
trypsin nor allowed enough time to enter the cell. Isc was mea-
sured for 30 min. Chamber fluid from cells collected at 2 h
after infection was able to induce ion secretion in noninfected
cells (figure 3). The effect was further enhanced with the fluid
collected at 24 h after infection. No electrical effect was ob-
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Figure 3. Enterotoxic effect of chamber fluids from rotavirus (RV)–
infected cells. We investigated the presence of enterotoxic moieties re-
leased by RV-infected cells. Chamber fluids of RV-infected cells were
added to the apical compartment of noninfected enterocytes in the Ussing
chamber system. No secretory response was observed with chamber fluids
from control cells and from cells in which RV had not been allowed
enough time to efficiently infect (T0). In contrast, chamber fluids from
cells at 2 (T2) and 24 (T24) h after infection were able to stimulate ion
secretion in noninfected Caco-2 cells. * , compared with control;P ! .05
** , compared with control. Isc, short circuit current.P ! .01
Figure 4. NSP4 detection in Caco-2 enterocytes infected with rotavirus.
The demonstration of NSP4 production in Caco-2 cells infected with
rotavirus was performed by western blot (WB) in cell lysates (top panel)
and after immunoprecipitation (IP) (bottom panel). WB showed NSP4 from
cells at 6 h after infection and a stronger band at 24 h after infection.
Increased sensitivity was obtained by immunoprecipitation, allowed the
detection of NSP4 starting at 1 h after infection and allowed detection
with a stronger signal at later time points.
served when rotavirus was not allowed to effectively infect cells
(figure 3).
NSP4 production by Caco-2 cells infected with rotavirus.
Western blotting with lysates from cells at different time points
after infection showed NSP4 at 6 h after infection, and a stron-
ger signal was evident at 24 h after infection (figure 4). Im-
munoprecipitation experiments were also performed to en-
hance the sensitivity of detection, and this second set of
experiments revealed the presence of NSP4 as early as 1 h af-
ter infection. At 24 h after infection, production of NSP4 was
further increased (figure 4). We also performed experiments in
cell supernatants, but NSP4 was inconsistently detected (data
not shown).
Effect of human Igs and anti-NSP4 antibodies on rotavirus
cytotoxic and enterotoxic effects. Human Igs were added to
rotavirus-infected cells at 1 h after infection, and filters were
mounted in Ussing chambers. Incubation with Igs completely
abolished rotavirus-induced secretion at all time points (figure
5). In parallel experiments, human Igs were effective in the
inhibition of both anion secretion and transepithelial resistance
decrease (figure 6). Next, we tested the effect of incubation with
specific anti-NSP4 antibodies after rotavirus infection. Anti-
NSP4114–135 Igs were effective in completely abolishing ion se-
cretion induced by rotavirus infection (figure 6A). No effect
was observed for anti-NSP4t. In contrast to human Igs, addition
of anti-NSP4114–135 and anti-NSP4fl did not affect cell damage
induced by rotavirus infection (figure 6B).
DISCUSSION
Rotavirus causes diarrhea through multiple mechanisms. There
is convincing evidence, mainly from animal models, of a de-
creased absorption of electrolytes and glucose/amino acids dur-
ing rotavirus diarrhea [6, 7]. Furthermore, enzymatic activities
of the brush border are markedly decreased, and paracellular
permeability is increased [6, 7]. Recently, secretory mechanisms
have been also described and associated with a viral enterotoxin
(NSP4) or with the stimulation of the enteric nervous system
[15, 34]. It is a common clinical observation that rotavirus
diarrhea occurs with an abrupt onset and massive fluid loss,
followed by a milder and more prolonged phase, possibly with
transient carbohydrate intolerance and nutrient malabsorption.
This clinical pattern is consistent with data from animal models,
in which histological changes are preceded by diarrhea induced
by rotavirus [11–14].
We set up an experimental model of rotavirus infection in
fully differentiated Caco-2 cells, and we were able to detect and
characterize a rotavirus-induced enterotoxic effect in entero-
cytes, in the early phases of infection. The enterotoxic effect
consisted of Cl secretion with a Ca2+-dependent mechanism.
The role of calcium in our model is consistent with previous
observations in other models where Ca2+ is required for both
rotavirus internalization and ion secretion [35]. Following early
ion secretion, cell lysis and tissue damage were observed, as
demonstrated by the decrease in transepithelial resistance. Thus,
in our model of rotavirus infection in vitro, a biphasic response
is observed, which parallels the distinct clinical phases. This is
the first experimental evidence, to our knowledge, of the se-
quential secretory and osmotic pathway of diarrhea in a hu-
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Figure 5. Inhibition of rotavirus (RV)–induced ion secretion by human
serum immunoglobulins (Igs). Addition of human serum Igs to RV-infected
cells was able to completely abolish the increase in short circuit current
(Isc) induced by RV (white triangles), compared with RV-infected cells
(black squares). Inhibition of ion secretion was evident at all time points
after infection.
Figure 6. Differential effects of human serum immunoglobulins (Igs)
and specific anti-NSP4 antibodies on ion secretion and cell damage in-
duced by rotavirus (RV) in Caco-2 cells. A, The effect on ion secretion
of human serum Igs and anti-NSP4114–135 antibodies was addressed by
their addition to RV-infected enterocytes and subsequent Isc measure-
ments. Results were compared with noninfected (control) and RV-infected
cells. Both human serum Igs (RV + Ig) and specific anti-NSP4114–135 (RV
+ anti-NSP4) antibodies were able to block RV-induced ion secretion.
* , compared with RB-infected, and Pp not significant, comparedP ! .01
with control. B, The effect on cell damage of human serum Igs and anti-
NSP4114–135 antibodies was addressed by their addition to RV-infected
enterocytes and subsequent transepithelial resistance (TER) measure-
ments. Results were compared with noninfected (control) and RV-infected
cells. Human serum Igs (RV + Ig) were able to prevent RV-induced cell
damage, whereas specific anti-NSP4114–135 (RV + anti-NSP4) antibodies
did not modify the decreased in TER exerted by RV. * , comparedP ! .01
with RB-infected; ** , compared with vs RV + Ig, and P p notP ! .01
significant, compared with RV-infected. Isc, short circuit current.
man-derived model. The dual mechanism may well explain the
increased severity of rotavirus diarrhea, compared with that
induced by other agents.
Because functional evidence of the enterotoxic effect sug-
gested that NSP4 could be involved, we looked for direct proof
of its role. The first evidence came from the secretory effect of
chamber fluids from rotavirus-infected cells when added to
noninfected Caco-2 monolayers. This is the typical effect ob-
served by enterotoxins with a Ca2+-dependent chloride secre-
tion. Direct NSP4 detection led to the demonstration of its
presence in the very early phases of infection, coinciding with
ion secretion observed in Ussing chambers. The detection of
NSP4 in cell lysates, and not in chamber fluids, from infected
cells may be ascribed to different experimental conditions in
the 2 sets of experiments. A recent study failed to demonstrate
ion secretion in rotavirus-infected Caco-2 cells [36]. However,
a different rotavirus strain was used, which may account for
the production of different nontoxic NSP4 variants [19, 37].
Moreover, in our model, the secretory peak was detected at 2
h after infection, whereas in the other study, events were in-
vestigated 4–24 h after infection, when most of ion secretion
has already occurred [36].
The more direct evidence pointing to the role of NSP4 was
the abrogation of rotavirus-induced ion secretion by anti-NSP4
antibodies. Next, we tested the efficacy of human Igs in this
model of rotavirus infection in vitro. Igs are effective in re-
ducing the duration and intensity of diarrhea when orally ad-
ministered to children with acute rotavirus gastroenteritis [23,
24]. We previously suggested that specific anti-rotavirus anti-
bodies were responsible for the inactivation and clearance of
rotavirus [22]. Here, we show that the early secretion induced
by rotavirus is completely inhibited by human Igs. This effect
is in keeping with the clinical observation that orally admin-
istered Igs have a potent therapeutic effect in the very early
phases of rotavirus diarrhea [23]. Thus, Igs are effective on
both the enterotoxic and the cytotoxic effects exerted by ro-
tavirus in this in vitro model of infection. A possible expla-
nation would be the presence of anti-NSP4 antibodies in hu-
man serum preparations, though this remains to be investigated.
A major issue in the study of recently released and potential
rotavirus vaccines is the definition of reliable and consistent cor-
relates of protection [38–40]. Our results support the concept
that anti-VP4 and VP7 antibodies may be insufficiently correlat-
ed to an effective anti-rotavirus condition, because of a potential
role of anti-NSP4 Ig.
In conclusion, for the first time, to our knowledge, we di-
rectly demonstrated that rotavirus diarrhea has dual secretory
and osmotic mechanism, and that the virus strikes the enter-
ocyte with a precise chronological sequence. NSP4 is a central
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factor in ion secretion in human-derived enterocytes, and hu-
man Igs are able to effectively block both phases of diarrhea.
This study supports the concept that local immune response
and specific anti-NSP4 humoral response should be investi-
gated as candidate correlates of protection in rotavirus diarrhea
and of vaccination.
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